Purchase
Description
Omalizumab biosimilar is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE). The antibody has a molecular weight of approximately 149 kiloDaltons. Omalizumab is produced by a Chinese hamster ovary cell suspension culture in a nutrient medium.
Omalizumab biosimilar is supplied at a concentration of 125 mg/mL as a sterile, preservative-free, clear solution, which contains 1.5 mg/mL L-histidine, 2.33 mg/mL L-histidine hydrochloride monohydrate, 0.417 mg/mL polysorbate 20 and 121.25 mg/mL sucrose.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Omalizumab biosimilar
|
|
CAS
NO.
|
242138-07-4
|
|
Type
|
Whole
antibody
|
|
Source
|
Humanized (from mouse)
|
|
Target
|
IgE Fc
region
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
149 kDa
|
|
Formula
|
C6450H9916N1714O2023S38
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154665386538.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Omalizumab
|
